TheraSource is a growing biotech company located in the Greater New York area. Our mission is to develop novel anti-inflammatory therapeutics for the treatment of human diseases. TheraSource is currently focused on the development of newly-discovered molecules to treat patients with ischemic acute kidney injury (AKI) and acute radiation injury.
TheraSource's R&D unit resides at The Feinstein Institute for Medical Research, which is equipped with a state-of-the-art preclinical testing facility. Our research team currently consists of 9 scientists with MD or PhD degrees in multidisciplinary areas, including protein chemistry, cell biology, immunology, pathophysiology, and clinical medicine. The company possesses 14 utility patents covering 5 molecules to treat selected inflammatory human diseases.
Company Details
- Employees
- 10
- Founded
- 2004
- Address
- 59 Highland Ave, Roslyn,new York 11576-2011,united States
- Industry
- Research
- Website
- therasourcellc.com
- Keywords
- Preclinical studies, Drug development, Biotechnology, Radiation countermeasures, Kidney disease prevention and treatment, Ischemia and reperfusion injury.
- HQ
- Roslyn, New York
Therasource, Lllc Questions
Therasource, Lllc's website is therasourcellc.com
Therasource, Lllc's LinkedIn profile is https://www.linkedin.com/company/therasource-llc
Therasource, Lllc has
10 employees.
View email and phone details for 10
employees at Therasource, Lllc.
Therasource, Lllc's industry is
Research
Therasource, Lllc's top competitors are
Affina Biotechnologies, Inc.,
United Biomedical, Inc. (Ubi),
Therabot,
Curemark, Llc,
Teledyne Lecroy,
Acorda Therapeutics, Inc.,
Humane Genomics,
Technovax, Inc.,
Fougera Pharmaceuticals Inc.,
United Therapy Services.
Therasource, Lllc's categories are Research
Therasource, Lllc's founding year is 2004
